Pharmaceutical Technology: News, Analysis & Industry Insights

News

Eli Lilly’s tirzepatide outperforms big pharma companies in Q3

Sales for Eli Lilly’s Mounjaro and Zepbound topped $16bn, exceeding total revenue for many big pharma players.

Robert Barrie

News

RFK Jr backs compounding of six unapproved peptides in new policy

Annabel Kartal Allen

News

Dren Bio raises $350m for dibotatug clinical development

Salong Debbarma

PremiumAnalyst Comment

IDWeek 2026: Abrysvo data in nursing home residents could support re-vaccination

Features

Podcast: ESMO26: Major readouts from the 2026 congress

News

UK Budget light on life sciences but more doors open for biotech startups

News

Formation Bio launches $600m drug development fund

News

Enthorin and Rumi sign agreement for FXS therapy

Analysis

PremiumAnalyst Comment

IDWeek 2026: early ensitrelvir PEP may benefit breakthrough and established Covid-19

GlobalData Healthcare

PremiumAnalyst Comment

IDWeek 2026: ISL/LEN on track to become the first once-weekly oral HIV therapy

GlobalData Healthcare

Features

Prediction markets herald insider trading risks for private biotechs

Frankie Fattorini

PremiumAnalyst Comment

Gaelic Labs: the EU Critical Medicines Act will have a positive impact on supply

Dominic Tyer

Themes

News

Anthropic plots IPO amid ongoing foray into drug development

Anthropic hopes Powerful AI will “match or exceed the cognitive capabilities of top human experts across scientific disciplines”.

More themes

Partner Content

Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity

News

Australia starts investigation into OpenAI Medicare breach

Partner Content

How DFE Pharma supports confident continuous manufacturing decisions

Partner Content

Industry partnership will determine the success of the transition to low-GWP pMDIs

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

CRO Activity and Intel Report Q3 2026

$1870.00

M&A in the Contract Manufacturing Industry: Implications and Outlook - 2026 Edition

$4995.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

RFK Jr backs compounding of six unapproved peptides in new policy

Dren Bio raises $350m for dibotatug clinical development

IDWeek 2026: Abrysvo data in nursing home residents could support re-vaccination

Podcast: ESMO26: Major readouts from the 2026 congress

UK Budget light on life sciences but more doors open for biotech startups

Formation Bio launches $600m drug development fund

Enthorin and Rumi sign agreement for FXS therapy

IDWeek 2026: early ensitrelvir PEP may benefit breakthrough and established Covid-19

IDWeek 2026: ISL/LEN on track to become the first once-weekly oral HIV therapy

Prediction markets herald insider trading risks for private biotechs

Gaelic Labs: the EU Critical Medicines Act will have a positive impact on supply

Anthropic plots IPO amid ongoing foray into drug development

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

CRO Activity and Intel Report Q3 2026

M&A in the Contract Manufacturing Industry: Implications and Outlook - 2026 Edition

Bio/Pharmaceutical Outsourcing Report, September 2026

IDWeek 2026: Pre-Conference Coverage

Gonorrhea: Market View, Current and Future Competitive Landscape

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

CRO Activity and Intel Report Q3 2026

M&A in the Contract Manufacturing Industry: Implications and Outlook - 2026 Edition

Bio/Pharmaceutical Outsourcing Report, September 2026

IDWeek 2026: Pre-Conference Coverage

Gonorrhea: Market View, Current and Future Competitive Landscape

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing